Novel roles of neuropeptide processing enzymes: EC3.4.24.15 in the neurome

✍ Scribed by S.I. Kim; V. Grum-Tokars; T.A. Swanson; E.J. Cotter; P.A. Cahill; J.L. Roberts; P.M. Cummins; M.J. Glucksman

• Publisher: John Wiley and Sons
• Year: 2003
• Tongue: English
• Weight: 409 KB
• Volume: 74
• Category: Article
• ISSN: 0360-4012
• DOI: 10.1002/jnr.10779

✦ Synopsis

Abstract

Neuropeptide processing metalloenzymes, such as angiotensin converting enzyme, neprilysin, endothelin converting enzyme, neurolysin, and EC3.4.24.15 (EP24.15), are central to the formation and degradation of bioactive peptides. We present EP24.15 as a paradigm for novel functions ascribed to these enzymes in the neurome. Although the neurome typically encompasses proteomes of the brain and central nervous system, exciting new roles of these neuropeptidases have been demonstrated in other organ systems. We discuss the involvement of EP24.15 with clinical sequelae involving the use of gonadotropin‐releasing hormone (GnRH; LHRH) analogs that act as enzyme inhibitors, in vascular physiology (blood pressure regulation), and in the hematologic system (immune surveillance). Hemodynamic forces, such as cyclic strain and shear stress, on vascular cells, induce an increase in EP24.15 transcription, suggesting that neuropeptidase‐mediated hydrolysis of pressor/depressor peptides is likely regulated by changes in hemodynamic force and blood pressure. Lastly, EP24.15 regulates surface expression of major histocompatibility complex Class I proteins in vivo, suggesting that EP24.15 may play an important role in maintenance of immune privilege in sites of increased endogenous expression. In these extraneural systems, regulation of both neuropeptide and other peptide substrates by neuropeptidases indicates that the influence of these enzymes may be more global than was anticipated previously, and suggests that their attributed role as neuropeptidases underestimates their physiologic actions in the neural system. © 2003 Wiley‐Liss, Inc.